XW001: Clinical Trials

2 trials of XW001, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1
Phase 11Completed 1

Follow XW001: new trials by email Literature Review of XW001 trials Research Report on XW001

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV
XW001, Placebo - RSV Infection
Phase 1 / Phase 2CompletedHangzhou Sciwind Biosciences Co., Ltd.612023-04-202025-08-17
Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy
XW001, Placebo - COVID-19 Acute Respiratory Distress Syndrome
Phase 2WithdrawnSciwind Biosciences APAC CO Pty. Ltd.2021-10-302023-08-21

Conditions studied

Respiratory Distress Syndrome (1)  ·  Respiratory Syncytial Virus Infections (1)

Sponsors

Hangzhou Sciwind Biosciences Co., Ltd. (1)  ·  Sciwind Biosciences APAC CO Pty. Ltd. (1)

Countries

Argentina (1)  ·  China (1)  ·  Peru (1)

Top investigators

Eddie Angles (1)  ·  Hanmin Liu, Dr (1)  ·  Qin Yu (1)  ·  Ricardo Teijeiro (1)